Literature DB >> 23933400

Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.

Richard P Davis1, Csilla Nemes, Eszter Varga, Christian Freund, Georgios Kosmidis, Konstantinos Gkatzis, Danielle de Jong, Károly Szuhai, András Dinnyés, Christine L Mummery.   

Abstract

Transposon gene delivery systems offer an alternative, non-viral-based approach to generate induced pluripotent stem cells (iPSCs). Here we used the Sleeping Beauty (SB) transposon to generate four human iPSC lines from foetal fibroblasts. In contrast to other gene delivery systems, the SB transposon does not exhibit an integration bias towards particular genetic elements, thereby reducing the risk of insertional mutagenesis. Furthermore, unlike the alternative transposon piggyBac, SB has no SB-like elements within the human genome, minimising the possibility of mobilising endogenous transposon elements. All iPSC lines exhibited the expected characteristics of pluripotent human cells, including the ability to differentiate to derivatives of all three germ layers in vitro. Re-expression of the SB transposase in the iPSCs after reprogramming resulted in the mobilisation of some of the transposons. These results indicate that the SB transposon system is a useful addition to methods for generating human iPSCs, both for basic and applied biomedical research, and in the context of future therapeutic application.
© 2013 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Differentiation; Human Induced pluripotent stem cell; Nuclear reprogramming; Sleeping Beauty transposon; Transfection methods

Mesh:

Substances:

Year:  2013        PMID: 23933400     DOI: 10.1016/j.diff.2013.06.002

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

Review 1.  Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Taruna Anand; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 2.  Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Authors:  I K Rony; A Baten; J A Bloomfield; M E Islam; M M Billah; K D Islam
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

3.  Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming.

Authors:  Thirumala R Talluri; Dharmendra Kumar; Silke Glage; Wiebke Garrels; Zoltan Ivics; Katharina Debowski; Rüdiger Behr; Heiner Niemann; Wilfried A Kues
Journal:  Cell Reprogram       Date:  2015-04       Impact factor: 1.987

Review 4.  The future of stem cell therapy in hernia and abdominal wall repair.

Authors:  A H Petter-Puchner; R H Fortelny; S Gruber-Blum; H Redl; U Dietz
Journal:  Hernia       Date:  2014-08-14       Impact factor: 4.739

Review 5.  Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.

Authors:  Marinka Brouwer; Huiqing Zhou; Nael Nadif Kasri
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

Review 6.  Preclinical and clinical advances in transposon-based gene therapy.

Authors:  Jaitip Tipanee; Yoke Chin Chai; Thierry VandenDriessche; Marinee K Chuah
Journal:  Biosci Rep       Date:  2017-12-05       Impact factor: 3.840

7.  Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy.

Authors:  Akram Al Abbar; Siew Ching Ngai; Nadine Nograles; Suleiman Yusuf Alhaji; Syahril Abdullah
Journal:  Biores Open Access       Date:  2020-04-28

Review 8.  Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering.

Authors:  Nicolás Sandoval-Villegas; Wasifa Nurieva; Maximilian Amberger; Zoltán Ivics
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 9.  Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools.

Authors:  Nafiseh Nafissi; Marianna Foldvari
Journal:  Front Neurosci       Date:  2015-10-14       Impact factor: 4.677

10.  Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.

Authors:  Adekunle Ebenezer Omole; Adegbenro Omotuyi John Fakoya
Journal:  PeerJ       Date:  2018-05-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.